The company aims to provide services in the healthcare sector, particularly the establishment and management of a bank of human stem cells, which are specifically obtained from umbilical cord and placental blood, umbilical cord tissue, and other sources, and all further activities related thereto. The company may participate in other companies, acquire, develop, manage, broker, and sell licenses, patents, and other intangible assets as well as real estate. It may establish branches and subsidiaries both domestically and abroad and generally conduct all business that is related to the purpose of the company or suitable to promote it. The company may grant direct or indirect financing to third parties or companies in which it is directly or indirectly involved, as well as to direct or indirect shareholders or companies in which such parties are directly or indirectly involved, either through loans and/or other financing. The company may provide securities of any kind for its own liabilities or the liabilities of the aforementioned persons, including through pledges, assignments, fiduciary transfers, guarantees of any kind, or through compensation obligations, whether for consideration or not, even if such financing, securities, or guarantees are exclusively in the interest of third parties or companies in which it is directly or indirectly involved, or of direct or indirect shareholders or companies in which such parties are directly or indirectly involved.